ACADIA PHARMACEUTICALS INC. (ACAD) Operating cash flow 2016–2025
ACADIA PHARMACEUTICALS INC. (ACAD) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$109.8MFY2025 · since FY2016: -$208.4M → $109.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $109.8M | -30.4% |
| FY2024 | $157.7M | +844.3% |
| FY2023 | $16.7M | +114.6% |
| FY2022 | -$114.0M | +9.3% |
| FY2021 | -$125.7M | +7.7% |
| FY2020 | -$136.2M | +9.9% |
| FY2019 | -$151.1M | +9.8% |
| FY2018 | -$167.5M | +23.1% |
| FY2017 | -$217.8M | -4.5% |
| FY2016 | -$208.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice